166 related articles for article (PubMed ID: 37623041)
21. Effect of hepcidin antagonists on anemia during inflammatory disorders.
Sagar P; Angmo S; Sandhir R; Rishi V; Yadav H; Singhal NK
Pharmacol Ther; 2021 Oct; 226():107877. PubMed ID: 33895185
[TBL] [Abstract][Full Text] [Related]
22. Iron deficiency screening is a key issue in chronic inflammatory diseases: A call to action.
Cacoub P; Choukroun G; Cohen-Solal A; Luporsi E; Peyrin-Biroulet L; Peoc'h K; Andrieu V; Lasocki S; Puy H; Trochu JN
J Intern Med; 2022 Oct; 292(4):542-556. PubMed ID: 35466452
[TBL] [Abstract][Full Text] [Related]
23. Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress.
Zhang DL; Ghosh MC; Ollivierre H; Li Y; Rouault TA
Blood; 2018 Nov; 132(19):2078-2087. PubMed ID: 30213870
[TBL] [Abstract][Full Text] [Related]
24. Rheumatoid anemia.
Masson C
Joint Bone Spine; 2011 Mar; 78(2):131-7. PubMed ID: 20851655
[TBL] [Abstract][Full Text] [Related]
25. Anemic copper-deficient rats, but not mice, display low hepcidin expression and high ferroportin levels.
Jenkitkasemwong S; Broderius M; Nam H; Prohaska JR; Knutson MD
J Nutr; 2010 Apr; 140(4):723-30. PubMed ID: 20164366
[TBL] [Abstract][Full Text] [Related]
26. Role of Hemoglobin Content of Reticulocyte to Evaluate Anemia in Patients with Malignancy.
Singh G; Chaudhry S; Kumawat A; Kumar G; Singh R
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443540
[TBL] [Abstract][Full Text] [Related]
27. Iron Deficiency and Iron Deficiency Anemia in Women with and without Obesity: NHANES 2001-2006.
Aguree S; Owora A; Hawkins M; Reddy MB
Nutrients; 2023 May; 15(10):. PubMed ID: 37242155
[TBL] [Abstract][Full Text] [Related]
28. The Prevalence of Iron and Vitamin D Deficiencies in Pediatric Patients With Inflammatory Bowel Disease in Bahrain.
Isa HM; Alahmed FA; Mohamed M; Mohamed A
Cureus; 2023 Apr; 15(4):e37074. PubMed ID: 37143618
[TBL] [Abstract][Full Text] [Related]
29. Association between iron deficiency and hospitalization rate in community-dwelling older adults: A 3-year prospective observational study of DO-HEALTH.
de Godoi Rezende Costa Molino C; Woll L; Wieczorek M; Abderhalden LA; Lanz P; Schaer DJ; Spahn DR; Orav EJ; Egli A; Bischoff-Ferrari HA;
Am J Clin Nutr; 2023 Jan; 117(1):12-21. PubMed ID: 36789930
[TBL] [Abstract][Full Text] [Related]
30. Anemia, hematinic deficiencies, hyperhomocysteinemia, and gastric parietal cell antibody positivity in atrophic glossitis patients with iron deficiency.
Chiang CP; Wu YC; Chang JY; Wang YP; Wu YH; Sun A
J Formos Med Assoc; 2020 Feb; 119(2):587-594. PubMed ID: 31607629
[TBL] [Abstract][Full Text] [Related]
31. Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma.
Huang Y; Ren GP; Xu C; Dong SF; Wang Y; Gan Y; Zhu L; Feng TY
BMC Cancer; 2014 Jul; 14():479. PubMed ID: 24989027
[TBL] [Abstract][Full Text] [Related]
32. Sevoflurane anesthesia during pregnancy in mice induces cognitive impairment in the offspring by causing iron deficiency and inhibiting myelinogenesis.
Zuo Y; Li B; Xie J; Ma Z; Thirupathi A; Yu P; Gao G; Zhou J; Zhou C; Xu H; Chang Y; Shi Z
Neurochem Int; 2020 May; 135():104693. PubMed ID: 32035889
[TBL] [Abstract][Full Text] [Related]
33. A new prognosis prediction model combining TNM stage with MAP2K4 and JNK in postoperative pancreatic cancer patients.
Liu XD; Zhang ZW; Wu HW; Liang ZY
Pathol Res Pract; 2021 Jan; 217():153313. PubMed ID: 33341545
[TBL] [Abstract][Full Text] [Related]
34. Hepcidin in tumor-related iron deficiency anemia and tumor-related anemia of chronic disease: pathogenic mechanisms and diagnosis.
Shu T; Jing C; Lv Z; Xie Y; Xu J; Wu J
Eur J Haematol; 2015 Jan; 94(1):67-73. PubMed ID: 24954786
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma.
Li HB; Wang JL; Jin XD; Zhao L; Ye HL; Kuang YB; Ma Y; Jiang XY; Yu ZY
BMC Cancer; 2021 Sep; 21(1):1039. PubMed ID: 34530774
[TBL] [Abstract][Full Text] [Related]
36. Fat-Soluble Vitamin Deficiencies and Disruption of the Immune System in Pancreatic Cancer: A Vicious Cycle.
Aziz MH; van der Meulen J; Mustafa DAM; van Eijck CHJ
Pancreas; 2022 Sep; 51(8):923-929. PubMed ID: 36607936
[TBL] [Abstract][Full Text] [Related]
37. Effects of maternal iron status on placental and fetal iron homeostasis.
Sangkhae V; Fisher AL; Wong S; Koenig MD; Tussing-Humphreys L; Chu A; Lelić M; Ganz T; Nemeth E
J Clin Invest; 2020 Feb; 130(2):625-640. PubMed ID: 31661462
[TBL] [Abstract][Full Text] [Related]
38. CT Abnormalities of the Pancreas Associated With the Subsequent Diagnosis of Clinical Stage I Pancreatic Ductal Adenocarcinoma More Than 1 Year Later: A Case-Control Study.
Toshima F; Watanabe R; Inoue D; Yoneda N; Yamamoto T; Sasahira N; Sasaki T; Matsuyama M; Minehiro K; Tateishi U; Gabata T
AJR Am J Roentgenol; 2021 Dec; 217(6):1353-1364. PubMed ID: 34161128
[No Abstract] [Full Text] [Related]
39. Genetic hemoglobin disorders rather than iron deficiency are a major predictor of hemoglobin concentration in women of reproductive age in rural prey Veng, Cambodia.
Karakochuk CD; Whitfield KC; Barr SI; Lamers Y; Devlin AM; Vercauteren SM; Kroeun H; Talukder A; McLean J; Green TJ
J Nutr; 2015 Jan; 145(1):134-42. PubMed ID: 25527668
[TBL] [Abstract][Full Text] [Related]
40. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
